HHBT OTC
HH Biotechnology Holdings Company
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -50.0%
3Y: -100.0%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$8M
+0.0% ▲
Gross Profit
$2M
+0.0% ▲
Operating Income
$3M
+0.0% ▲
Net Income
$2M
+0.0% ▲
EPS (Diluted)
$0.18
+0.0% ▲
EBITDA
$5M
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2015 |
|---|---|
| Revenue | $8M |
| YoY Growth | +0.0% |
| Cost of Revenue | $6M |
| Gross Profit | $2M |
| Gross Margin | 29.5% |
| R&D Expenses | $0 |
| SG&A Expenses | $0 |
| Operating Expenses | -$745K |
| Operating Income | $3M |
| Operating Margin | 38.8% |
| Interest Expense | $874K |
| Income Before Tax | $3M |
| Tax Expense | $231K |
| Net Income | $2M |
| Net Margin | 31.0% |
| EPS (Diluted) | $0.18 |
| EBITDA | $5M |
| Shares Outstanding | 14M |